| Net income | |
| Depreciation and amortization | |
| Provision for doubtful accounts | |
| Non-cash stock-based compensation | 6.76M |
| Excess tax benefits from stock-based payment arrangements | |
| Disposal of property and equipment | |
| Amortization of deferred financing costs | |
| Write-off of deferred financing costs | |
| Deferred income taxes | |
| Amortization of discount and accretion on debt | |
| Accounts receivable | -136.38M |
| Payments on notes receivable | |
| Other current and non-current assets | |
| Accounts payable and accrued liabilities | 40.95M |
| Employee compensation and benefits | |
| Insurance liability risks | |
| Other long-term liabilities | |
| Net cash provided by operating activities | 35.3M |
| Additions to property and equipment | -70.79M |
| Acquistion of healthcare facilities and businesses | |
| Acquisition of home health licenses | |
| Proceeds from sale of property and equipment | |
| Net cash used in investing activities | 962K |
| Borrowings under line of credit | 662M |
| Repayments under line of credit | -611M |
| Repayments of long-term debt and capital leases | |
| Proceeds from issuance long-term debt | 354.14M |
| Additions to deferred financing costs | |
| Exercise of stock options | |
| Excess tax benefits from stock-based payment arrangements | |
| Taxes paid related to net share settlement of equity awards | |
| Net cash (used in) provided by financing activities | -43.97M |
| Increase (decrease) in cash and cash equivalents | -7.7M |
| Cash and cash equivalents at beginning of period | 61.54M |
| Cash and cash equivalents at end of period | 53.84M |